Deccan Health Care Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Deccan Health Care Ltd is ₹ 11.93 as of 23 Oct 15:30 . The P/E Ratio of Deccan Health Care Ltd changed from 117.6 on March 2021 to 6.8 on March 2026 . This represents a CAGR of -37.82% over 6 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Deccan Health Care Ltd changed from ₹ 46.2 crore on March 2021 to ₹ 16.95 crore on March 2026 . This represents a CAGR of -15.39% over 6 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Deccan Health Care Ltd for the Jun '26 is ₹ 22.09 crore as compare to the Mar '26 revenue of ₹ 20.98 crore. This represent the growth of 5.29% The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The ebitda of Deccan Health Care Ltd for the Jun '26 is ₹ 0.93 crore as compare to the Mar '26 ebitda of ₹ 0.89 crore. This represent the growth of 4.49% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The net profit of Deccan Health Care Ltd changed from ₹ 0.36 crore to ₹ 0.29 crore over 9 quarters. This represents a CAGR of -9.16% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Deccan Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Deccan Health Care Ltd

Incorporated on August 31, 2017, Deccan Health Care Limited is developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products.
With an operating history of more than two decades, the company is primarily known for premium range of nutraceutical, ayurveda and cosmeceutical products.
The Company has identified over 80 consumer wellness goals and over 250 diseases, disorders, disabilities which can be prevented by meeting RDA of micronutrients and it has innovated and developed cost effective products that are unique and differentiated to combat such diseases. The Company was initially engaged in trading of Pharmaceuticals till 2005.
From 2005 till 2010 the company was engaged in third party manufacturing.
From 2010 onwards, the Company set up its own Manufacturing Facility at Rudrapur, Uttarakhand.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Deccan Health Care Ltd and null

Which company has a larger market capitalization, Deccan Health Care Ltd or Molbio Diagnostics Ltd?

Market cap of Deccan Health Care Ltd is 29 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Deccan Health Care Ltd and Molbio Diagnostics Ltd?

The stock performance of Deccan Health Care Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deccan Health Care Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Deccan Health Care Ltd stock price is INR ₹11.93. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Deccan Health Care Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Deccan Health Care Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.